The 1st International Workshop on Acute Leukemias (iwAL) took place on February 16–18, 2018, in St. Pete’s Beach, FL. iwAL was established to encourage interactive debates and discussions on AML and ALL.
VJHemOnc is pleased to bring you e-learning webcasts from iwAL 2018! Whether you were not able to attend in person or you want to experience it all again, all eight educational sessions are available to watch at your convenience. Covering the key topics in AL, including MRD, CAR T-cells, checkpoint inhibitors, novel drugs, trial design, and advances in epigenomics, the e-learning webcasts will bring you up to speed on the latest advances presented at iwAL 2018.
Featuring: Dr Ari Melnick
Weill Cornell Medicine
Epigenetic Landscape in Acute Leukemias
Featuring: Anjali Advani
Case Western Reserve University
Early T-cell precursor ALL
Featuring: Professor Wolfgang Hiddeman
LMU-University Hospital Munich
Featuring: Professor Daniel DeAngelo
Dana-Farber Cancer Institute
Targeting CD22+ ALL– Inotuzumab Ozogamicin
Featuring: Dr Farhad Ravandi
MD Anderson Cancer Center
Is MRD Already a Surrogate for Survival?
Featuring: Dr Andrew Wei
Monash University, Victoria, Australia
BCL-2 Inhibitors and Combinations – Venetoclax
Featuring: Dr Noelle Frey
University of Pennsylvania
CAR T-Cell Therapy in B-Cell ALL
Featuring: Professor Mark Levis
Sidney Kimmel Comprehensive Cancer Center
New Therapies for FLT3+ AML – Midostaurin, Gilteritinib & Quizartinib
Following on from a successful 1st International Workshop on Acute Leukemias, the 2nd iwAL workshop will take place in Barcelona, Spain, in 2019 next year.
For information about next year’s meeting, head over to the iwAL website
Keep a lookout for further latest clinical updates in acute leukemias, including advancements in MRD, epigenomics, immunotherapy and trial design.
By choosing to continue, you are confirming that you are a healthcare professional